Call for Abstract

26th Annual Conference on Clinical & Medical Case Reports in Cardiology, will be organized around the theme “Clinical and medical case studies that pave way for an advanced cardiology treatment”

Cardiology Case Reports 2018 is comprised of 13 tracks and 81 sessions designed to offer comprehensive sessions that address current issues in Cardiology Case Reports 2018.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

Heart diseases are the term used to indicate disorder of heart. Coronary artery disease is also known as ischemic heart disease. It is caused by atherosclerosis, that is the narrowing and / or blockage of the blood vessels that supply the heart. It is one of the most common forms of heart disease and the leading cause of heart attacks and angina. It does not cause chest pain. Most congenital heart problems do not present with other diseases. Complications that can result from heart defects include heart failure. Most common Heart Diseases are Silent like:-

  • Track 1-1Ischemia
  • Track 1-2Peripheral arterial disease
  • Track 1-3Heart attack
  • Track 1-4Systolic heart failure
  • Track 1-5Diastolic heart failure
  • Track 1-6Coronary artery disease

Valvular heart disease is a disease condition which involves valves of the heart that is the mitral, aortic, tricuspid or pulmonary. The mitral and aortic valves are the ones most frequently affected by Valvular heart disease. The most common heart valve conditions sometimes it causes regurgitation, Stenosis when the valve doesn't open enough and blocks blood flow. The main sign of heart valve disease is an unusual heart beat sound called a heart murmur.Valve problems can be present at birth or caused by infections and heart attacks or heart diseases.

  • Track 2-1Aortic and mitral valve disease
  • Track 2-2Pulmonary and tricuspid valve diseases
  • Track 2-3Congenital heart disease
  • Track 2-4Cerebrovascular disease
  • Track 2-5Rheumatic heart disease
  • Track 2-6Inflammatory heart disease
  • Track 2-7Peripheral arterial disease
  • Track 2-8Coronary artery disease

 It is a group of diseases that affect the heart muscle. Earlier there are only few or no symptoms, others may have shortness of breath, feel tired, or have swelling of the legs due to heart failure. An irregular heartbeat may occur as well as fainting and increased risk of sudden cardiac death also occurs. 

Pericardial effusion is an abnormal accumulation of fluid in the pericardial cavity. It leads to an increased Intra pericardial pressure which can negatively affect heart function. A pericardial effusion with enough pressure to adversely affect heart function is called cardiac tamponed. Pericardial effusion usually occurs due to disturbed equilibrium of the production and reabsorption of pericardial fluid, or from a structural abnormality that allows fluid to enter the pericardial cavity.

  • Track 3-1Dilated cardiomyopathy
  • Track 3-2Hypertrophic cardiomyopathy
  • Track 3-3Restrictive cardiomyopathy

Pediatric Cardiology concern all aspects of heart disease in infants, children, and adolescents, including embryology and anatomy, physiology and pharmacology, biochemistry, pathology, genetics, radiology, clinical aspects, investigative cardiology, electrophysiology and echocardiography, and cardiac surgery. Pediatric Cardiology is responsible for the diagnosis of congenital heart defects, performing diagnostic procedures such as echocardiograms, cardiac catheterizations and electrophysiology studies. The increasing number of neonates with congenital heart defects referred to the neonatal intensive care unit reflects the increasing awareness that the defects may be present. Chest radiography and ECG rarely assist in the neonatal diagnosis. Congestive heart failure in the fetus, or hydrops, can be detected by performing fetal echocardiography. Many of the pediatric heart defects such as :-

  • Track 4-1Patent ductus arteriosus interruption
  • Track 4-2Vascular ring division
  • Track 4-3Pericardial window
  • Track 4-4Diaphragm placation
  • Track 4-5Thoracic duct ligation
  • Track 4-6Ligation of collateral vessels

It also called cardiac dysrhythmia or irregular heartbeat. It is a condition in which the heartbeat is irregular, too fast, or too slow. It includes extra beats, supraventricular tachycardia, ventricular arrhythmias,  Brady arrhythmias. Many types of arrhythmia have no symptoms. When symptoms are present these may include palpitations or feeling a pause between heartbeats. More seriously there may be lightheadedness, passing out, shortness of breath, or chest pain, some predispose a person to complications such as stroke or heart failure. Others may result in cardiac arrest.

  • Track 5-1Tachycardia
  • Track 5-2Bradycardia
  • Track 5-3Atrial fibrillation
  • Track 5-4Ventricular fibrillation
  • Track 5-5Ventricular tachycardia
  • Track 5-6Supraventricular tachycardia

Arteriosclerosis is a condition in which an artery wall thickens because of invasion and accumulation of white blood cells. It is caused by the build-up of fatty plaques. Plaque creates a bump on the artery wall. As atherosclerosis progresses, that bump gets bigger. When it gets big enough, it can create a blockage. That process goes on throughout your entire body. As a result, not only is your heart at risk, but you are also at risk for stroke and other health problems

  • Track 6-1Cerebrovascular disease
  • Track 6-2Peripheral arterial disease
  • Track 6-3Angioplasty and stent placement
  • Track 6-4Bypass surgery

It is a long term medical condition in which the blood pressure in the arteries is persistently elevated. Pulmonary hypertension or PH is a disease where hypertension in the lungs can be seen. Idiopathic pulmonary hypertension disease makes the person difficult to breathe. A few people with the diseases require additional oxygen.

  • Track 7-1Primary hypertension
  • Track 7-2Secondary hypertension
  • Track 7-3Isolated systolic hypertension
  • Track 7-4Malignant hypertension
  • Track 7-5Coronary artery disease
  • Track 7-6Systolic/Diastolic malfunction
  • Track 7-7Pulmonary regurgitation
  • Track 7-8Resistant hypertension
  • Track 7-9Indications and contraindications for antihypertensive drugs

Heart regeneration is a broad effort and comes into existence when the cardiac tissue is damaged and failed to regenerate the myocardium. Where the main principle behind cardiac regeneration is Reparative stem cells have the capability to restore function to damaged tissue by renewing cell growth in cardiac cells destroyed by heart disease. Reparative tools have been engineered to restore damaged heart tissue and function using the body's natural ability to regenerate.

  • Track 8-1Tissue graft cardiac cell replacement
  • Track 8-2Cardiac remodeling
  • Track 8-3Cardiac regenerative therapy
  • Track 8-4Congenital heart disease and regeneration
  • Track 8-5Heart repair, heart tissue regeneration and stem cells
  • Track 8-6Biomimetic heart valve replacement
  • Track 8-7Stem cell-derived engineered cardiac tissue

The cardiac and cardiovascular research focuses on the treatment of diseases and new theories of diagnosis of the blood vessels and the vascular system or hears research across different disciplines.  It seeks to enhance insight into cardiovascular disease mechanisms and the prospects for innovation and performs cutting edge research illuminating cardiovascular and pulmonary biology and disease and trains clinicians and scientists to become future leaders of these fields.

  • Track 9-1Percutaneous transluminal coronary angioplasty
  • Track 9-2Echocardiography (ECG)
  • Track 9-3 Coronary angiography
  • Track 9-4Myocardial biopsy
  • Track 9-5 Pericardiocentesis
  • Track 9-6Cardiac catheterization
  • Track 9-7Stent placement
  • Track 9-8Bypass surgery
  • Track 9-9Insertion of pacemaker

Heart disease diagnosis depends on what condition doctor thinks you might have. No matter what type of heart disease you have, doctor will likely perform a physical exam and ask about your personal and family medical history before doing any tests. Besides blood tests and a chest X-ray, tests to diagnose heart disease can include: 

  • Track 10-1Electrocardiogram
  • Track 10-2Nuclear cardiology
  • Track 10-3Catherization, cardiac angiography
  • Track 10-4Exercise stress testing
  • Track 10-5Cardiac magnetic resonance imaging
  • Track 10-6Cardiac CT angiography

Heart Devices are electronic devices which is used either too partially or to completely replace the function of a failing heart. These wireless cardiac monitoring devices is marking a new era in medicine and a transition from population-level health care to individualized medicine in which suitable patients are equipped with advanced biosensors. The pacemaker, defibrillators, ventricular assist device. Biosensors are the heart devices used in treatment of heart diseases. Implanted medical devices may be recommended when other treatments don’t work. 

  • Track 11-1Pacemaker
  • Track 11-2Defibrillators
  • Track 11-3ventricular assist device
  • Track 11-4Biosensors

Cardiac surgery will be surgery on the heart performed by cardiac surgeons. Every now and again, it is done to treat inconveniences of ischemic coronary illness, amend inherent coronary illness, or treat valvular coronary illness from different causes including endocarditis, rheumatic coronary illness and atherosclerosis. It also includes heart transplantation. The advancement of cardiac surgery and cardiopulmonary bypass techniques has diminished the mortality rates of these surgeries to generally low positions. For instance, repairs of are currently assessed to have 4–6% death rates.

  • Track 12-1Heart transplantation
  • Track 12-2Open heart surgery
  • Track 12-3Cardiothoracic surgery
  • Track 12-4Bypass surgery
  • Track 12-5Pediatric cardiovascular surgery
  • Track 12-6 Invasive surgery
  • Track 12-7Aortic dissection

Future cardiology medicine reflects this new era of cardiology and highlights the new molecular approach to advancing cardiovascular therapy. It will also reveal the major technological advancement in bioengineering in cardiology in terms of advanced and robust devices, miniaturization, imaging, system modeling and information management issues.

  • Track 13-1Advanced device and imaging technologies
  • Track 13-2Molecular basis of cardiovascular disease
  • Track 13-3New diagnostic approaches, screening and patient stratification
  • Track 13-4‘Personalized medicine’ in cardiology
  • Track 13-5Therapeutic overviews highlighting optimal therapy and future options
  • Track 13-6Real-world evidence and outcomes research